Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
15%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
CANC
54
HOLDINGS
24%
ALSO IN SBIO
SBIO
87
HOLDINGS
16%
ALSO IN CANC
SECTOR DRIFT (CANC minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
| CG ONCOLOGY, INC. | 2.8% | 3.3% | 2.8% | |
| RELAY THERAPEUTICS, INC. | 1.8% | 2.3% | 1.8% | |
| IDEAYA BIOSCIENCES, INC. | 2.6% | 1.7% | 1.7% | |
| IMMUNOME, INC. | 2.8% | 1.3% | 1.3% | |
| ZAI LAB LTD. UNSPONSORED ADR | 1.6% | 1.2% | 1.2% | |
CANC Overweight Relative to SBIO
| REVOLUTION MEDICINES, INC. | 6.0% | |
| ELI LILLY & CO | 5.0% | |
| COGENT BIOSCIENCES INC | 5.0% | |
| ROCHE HOLDINGS LTD-SPONS ADR | 4.1% | |
| NOVARTIS AG | 4.1% | |
| ABBVIE INC | 3.7% | |
| MERCK & CO. INC. | 3.5% | |
| BRISTOL-MYERS SQUIBB CO | 3.4% | |
| JOHNSON & JOHNSON | 3.3% | |
| EXELIXIS INC | 2.8% |
CANC Underweight Relative to SBIO
| CRINETICS PHARMACEUTICALS INC | -4.6% | |
| APOGEE THERAPEUTICS, INC. | -4.4% | |
| DIANTHUS THERAPEUTICS INC | -3.0% | |
| ORUKA THERAPEUTICS INC | -2.9% | |
| TRAVERE THERAPEUTICS, INC. | -2.8% | |
| DEFINIUM THERAPEUTICS INC | -2.5% | |
| ACADIA PHARMACEUTICALS INC | -2.3% | |
| EDGEWISE THERAPEUTICS, INC. | -2.3% | |
| DYNE THERAPEUTICS INC | -2.1% | |
| NEWAMSTERDAM PHARMA CO NV | -1.9% |